Abstract
TARGETING TAU HYPERPHOSPHORYLATION IN ALZHEIMER’S DISEASE: EXPLORING NOVEL DYRK1A AND CLK1 KINASE INHIBITORS VIA STRUCTURE-BASED VIRTUAL SCREENING
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have